Ryan Donnelly (pharmaceutical scientist)

Last updated

Ryan Donnelly
Alma mater Queen's University Belfast
Scientific career
Institutions Queen's University Belfast
Thesis Bioadhesive drug delivery systems for photodynamic therapy of vulval intraepithelial neoplasia  (2003)
Website Professor Ryan Donnelly

Ryan Francis Donnelly has been a Chair of Pharmaceutical Technology at Queen's University Belfast since 2013. [1] His research focused on the design and physicochemical characterisation of advanced polymeric drug delivery systems for transdermal and topical applications. [1] [2] [3] [4]

He graduated with a first-class degree in Pharmacy from Queen's University Belfast in 1999, where he subsequently completed his PhD in pharmaceutics in 2003. [1]

He has an h-index of 78. [5]

Related Research Articles

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist is a healthcare professional who specializes in the preparation, dispensing, and management of medications and who provides pharmaceutical advice and guidance. Pharmacists often serve as primary care providers in the community, and may offer other services such as health screenings and immunizations.

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">UCL School of Pharmacy</span>

The UCL School of Pharmacy is the pharmacy school of University College London (UCL). The School forms part of UCL's Faculty of Life Sciences and is located in London, United Kingdom.

<span class="mw-page-title-main">Robert S. Langer</span> American scientist

Robert Samuel Langer Jr. FREng is an American biotechnologist, businessman, chemical engineer, chemist, and inventor. He is one of the twelve Institute Professors at the Massachusetts Institute of Technology.

<span class="mw-page-title-main">Monash University, Parkville campus</span>

Monash University, Parkville campus is a campus of Monash University, located in Parkville, Victoria, Australia. It is home to the Faculty of Pharmacy and Pharmaceutical Sciences. Founded in 1881 and previously known as the Victorian College of Pharmacy, the faculty is the oldest school of pharmacy in Australia. A major centre of research and teaching, it is internationally regarded for its research in drug target biology and discovery, medicinal chemistry, drug development, formulation science, and medicine use and safety, including the discovery and development of the world's first successful anti-influenza drug, Relenza. In international rankings, it is ranked as the number one school of pharmacy and pharmacology in Australia and number two worldwide.

Stanley Stuart (Bob) Davis is emeritus professor of pharmacy at the University of Nottingham.

<span class="mw-page-title-main">University of Kentucky College of Pharmacy</span> College of Pharmacy of the University of Kentucky in Lexington, KY, USA

The University of Kentucky College of Pharmacy is a college of pharmacy located in Lexington, Kentucky. In 2020, U.S. News & World Report recognized the UK College of Pharmacy as one of the nation's top ten pharmacy programs.

<span class="mw-page-title-main">Joseph R. Robinson</span> American pharmaceutical scientist (1939–2006)

Joseph R. Robinson was a pharmacy researcher and the Edward Kremers Emeritus Professor of Pharmacy in the School of Pharmacy at the University of Wisconsin–Madison. He was particularly known for his work on ophthalmological drug delivery and on bioadhesion.

Modified-release dosage is a mechanism that delivers a drug with a delay after its administration or for a prolonged period of time or to a specific target in the body.

<span class="mw-page-title-main">University of Florida College of Pharmacy</span> Pharmacy school in Gainesville, Florida

The University of Florida College of Pharmacy is the pharmacy school of the University of Florida. The College of Pharmacy was founded in 1923 and is located on the university's Gainesville, Florida main campus. The college offers the entry-level Doctor of Pharmacy (Pharm.D.) degree as the first professional degree for students entering the profession. The college offered a Working Professional Pharm.D. (WPPD) program for bachelor's-trained pharmacists already in practice with its last cohort of students enrolled in 2016. Additionally, various graduate degrees are offered. The professional program is fully accredited by the American Council on Pharmaceutical Education. Since 2011 the college has been offering online degree programs at the graduate level, such as the Forensic Science Program, Pharmaceutical Chemistry Program and Clinical Toxicology Program. In total the College of Pharmacy received over $32 million in total Research Revenues in 2021.

<span class="mw-page-title-main">Nicholas A. Peppas</span> Greek chemical and biomedical engineer (b. 1948)

Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale, macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.

Sir Allen McClay CBE was a Northern Irish multi-millionaire businessman and philanthropist who founded Galen, a pharmaceutical company which was Northern Ireland's first one billion pound business. After resigning from Galen in 2001, he went on to form a second successful pharmaceutical company, the Almac Group.

Aliasger K. Salem is the Associate Vice President for Research at the University of Iowa and Bighley Chair and Professor of Pharmaceutical Sciences at the University of Iowa College of Pharmacy. Salem's academic appointment at the University of Iowa is based in the College of Pharmacy, with additional secondary appointments in the College of Dentistry, Department of Chemical and Biochemical Engineering, Department of Biomedical Engineering, Department of Chemistry, and the Holden Comprehensive Cancer Center. Prior to joining the University of Iowa in 2004, he was a postdoctoral fellow at the Johns Hopkins School of Medicine and completed his PhD at the School of Pharmacy and Pharmaceutical Sciences at the University of Nottingham in the UK.

<span class="mw-page-title-main">Leslie Z. Benet</span>

Leslie 'Les' Zachary Benet is an influential pharmaceutical scientist heading the UCSF's Benet Lab at the Department of Bioengineering and Therapeutic Sciences and recipient of the Remington Medal for distinguished service to American pharmacy.

<span class="mw-page-title-main">Andreas Bernkop-Schnürch</span> Austrian university teacher (born 1965)

Andreas Bernkop-Schnürch is an Austrian scientist and entrepreneur. He is Head of the Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck. His research centers on the areas of drug delivery, dosage forms, controlled release, bionanotechnology, polymer engineering and tissue engineering. He is the inventor of several technologies such as thiolated polymers for that he coined the name thiomers in 2000 and phosphatase triggered charge-converting nanoparticles for mucosal drug delivery. Since 2014 he is on the scientific advisory board of the Nicotine Science Center, Denmark. From 2016 to 2018 he served as a member of the Scientific Committee of the Innovative Medicines Initiative (IMI) of the European Union in Brussels giving advice on scientific priorities to be included in the Strategic Research Agenda for Horizon 2020. He is member of the editorial board of numerous pharmaceutical journals including International Journal of Pharmaceutics, Journal of Drug Delivery Science and Technology, Scientia Pharmaceutica, Drug Development and Industrial Pharmacy and European Journal of Pharmaceutics and Biopharmaceutis. Andreas Bernkop-Schnürch is the founder of Thiomatrix Forschungs- und Beratungs GmbH, Mucobiomer Biotechnologische Forschungs- und Entwicklungs GmbH and Green River Polymers Forschungs und Entwicklungs GmbH. Since 2022 he is listed as a Highly Cited Researcher of the Institute of Scientific Information.

Mojisola Christianah Adeyeye is a Nigerian pharmacist and professor. She was appointed the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC) on 3 November 2017 by the President of The Federal Republic of Nigeria, Muhammadu Buhari. Before her appointment as NAFDAC boss, she was the founding Chair of Biopharmaceutical Sciences and a Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois, where she spent 7 years. She was also a Professor of Pharmaceutics and Manufacturing for 21 years at Duquesne University in Pittsburgh, Pennsylvania, USA. She is Senior Fulbright Scholar and Specialist and 2008 American Association of Pharmaceutical Scientists Fellow. She is also a Fellow of the Nigerian Academy of Science and Nigeria Academy of Pharmacy. Her research interests are in the areas of pre-formulation, early phase development of solid, semisolid and liquid dosage forms, and IND-based and intellectual property-driven late phase drug product development. She is the founder and President of Elim Pediatric Pharmaceuticals Rolling Meadows, Illinois. Through Duquesne University, she was able to develop an anti-retroviral (HIV/AIDS) pediatric fixed-dose combination and received intellectual property on the formulations in the UK and South Africa.

<span class="mw-page-title-main">Ijeoma Uchegbu</span> Nigerian-British pharmacist and Professor of Pharmacy

Ijeoma Uchegbu is a Nigerian-British Professor of Pharmacy at University College London where she held the position of Pro-Vice Provost for Africa and the Middle East. She is the Chief Scientific Officer of Nanomerics, a pharmaceutical nanotechnology company specialising in drug delivery solutions for poorly water-soluble drugs, nucleic acids and peptides. She is also a Governor of the Wellcome, a large biomedical research charity. Apart from her highly cited scientific research in Pharmaceutical Nanoscience, Uchegbu is also known for her work in science public engagement and equality and diversity in Science, Technology, Engineering and Mathematics (STEM). In December 2023, it was announced that she will become President of Wolfson College, Cambridge in October 2024.

<span class="mw-page-title-main">Microneedle drug delivery</span>

Microneedles or Microneedle patches or Microarray patches are micron-scaled medical devices used to administer vaccines, drugs, and other therapeutic agents. While microneedles were initially explored for transdermal drug delivery applications, their use has been extended for the intraocular, vaginal, transungual, cardiac, vascular, gastrointestinal, and intracochlear delivery of drugs. Microneedles are constructed through various methods, usually involving photolithographic processes or micromolding. These methods involve etching microscopic structure into resin or silicon in order to cast microneedles. Microneedles are made from a variety of material ranging from silicon, titanium, stainless steel, and polymers. Some microneedles are made of a drug to be delivered to the body but are shaped into a needle so they will penetrate the skin. The microneedles range in size, shape, and function but are all used as an alternative to other delivery methods like the conventional hypodermic needle or other injection apparatus.

<span class="mw-page-title-main">Fakhreddin Jamali</span> Iranian-Canadian pharmacist

Fakhreddin Jamali is an Iranian-Canadian professor emeritus of pharmacy and pharmaceutical sciences at the University of Alberta. He is the founding president of the Canadian Society for Pharmaceutical Sciences, and the editor-in-chief of Journal of Pharmacy and Pharmaceutical Sciences.

Kishor M. Wasan is a Canadian pharmacologist, pharmacist and professor. He was the dean of the University of Saskatchewan's College of Pharmacy and Nutrition from 2014 to 2019 and associate dean of research and graduate studies at the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) from 2011 to 2014. Previously at UBC, he was chair of pharmaceutics and national director of the Canadian Summer Student Research Program after first joining the faculty in 1995. Wasan's research focuses on lipid-based drug delivery and the interaction between lipoprotein and pharmaceuticals. He has published more than 550 peer-reviewed articles and abstracts. He is a founding member and co-director of UBC's Neglected Global Diseases Initiative.

References

  1. 1 2 3 "PROFESSOR RYAN DONNELLY". Queen's University Belfast . Retrieved 5 April 2018.
  2. Shaikh, Rahamatullah; Raj Singh, Thakur Raghu; Garland, Martin James; Woolfson, A. David; Donnelly, Ryan F. (2011). "Mucoadhesive drug delivery systems". Journal of Pharmacy and Bioallied Sciences. 3 (1): 89–100. doi: 10.4103/0975-7406.76478 . PMC   3053525 . PMID   21430958.
  3. "QUB team develops patch to tackle antibiotic resistance". ITV News . 5 January 2018. Retrieved 5 April 2018.
  4. "Dr Ryan Donnelly wins award for micro-needle 'painless injection' research". BBC News . 31 October 2012. Retrieved 5 April 2018.
  5. "Ryan F Donnelly". scholar.google.co.uk. Retrieved 30 January 2023.